OptiNose
OPTN
OPTN was delisted on the 20th of May, 2025.
71 hedge funds and large institutions have $102M invested in OptiNose in 2023 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 4 closing their positions.
275% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 4
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
33% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 18
18% more funds holding
Funds holding: 60 → 71 (+11)
12% more capital invested
Capital invested by funds: $90.5M → $102M (+$11.1M)
0.3% more ownership
Funds ownership: 4.38% → 4.68% (+0.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$436K |
| 2 |
EIP
Easterly Investment Partners
Beverly,
Massachusetts
|
+$321K |
| 3 |
BlackRock
New York
|
+$275K |
| 4 |
KCM
Kingdon Capital Management
New York
|
+$243K |
| 5 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$243K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
-$1.06M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$375K |
| 3 |
Millennium Management
New York
|
-$329K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$221K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$196K |
OPTN Hedge Fund Activity: Q4 2023 in Review
71 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q4 2023, worth a combined $102M — up 12% from $90.5M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new OPTN positions and 4 closed out — a net gain of 11 holders — while 24 added to existing stakes and 18 trimmed.
The largest buyer was Vanguard Group, adding an estimated $436K. The largest seller was GMT Capital, cutting an estimated $1.06M.
- 71 institutional investors held OptiNose (OPTN) as of Q4 2023, up from 60 in Q3 2023.
- Funds reported $102M of OptiNose stock for Q4 2023, up 12% quarter-over-quarter.
- 15 funds opened new OptiNose positions in Q4 2023 and 4 closed out, a net change of +11 holders.
- The largest OptiNose buyer in Q4 2023 was Vanguard Group, an estimated $436K added.
- The largest OptiNose seller in Q4 2023 was GMT Capital, an estimated $1.06M sold.
Based on aggregated 13F filings for Q4 2023.